EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality ...
Erasca has backed up bullish claims about its pan-RAS drug having a best-in-class profile, publishing phase 1 data that an ...
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality ...
D&D Pharmatech announced on the 16th that its metabolic dysfunction-associated steatotic liver disease (MASH) treatment, 'DD01,' has demonstrated efficacy in U.S. phase 2 clinical trials. DD01 is a ...
BARCELONA, Spain & HAYWARD, Calif.--(BUSINESS WIRE)--This week at CPHI Barcelona, Pharmatech Associates will showcase its expertise and capabilities that help global pharmaceutical and emerging ...
Digital medicine adoption, also referred to as digital therapeutics, was challenging ahead of the pandemic. Clinical validation and FDA clearances have gradually moved the needle on how these ...
GYEONGGI-DO, South Korea & GAITHERSBURG, Md.--(BUSINESS WIRE)--D&D Pharmatech, Inc. (D&D), a clinical-stage biotechnology company focused on development and commercialization of revolutionary ...
Drug developers want to speed up recruitment and retention of clinical trial participants. This is one area ripe for innovation, where need and demand intersect. At MedCity INVEST PharmaTech, the free ...
Tampa, FL-based Virtus Pharmaceuticals is recalling an intestinal treatment drug which it said failed potency tests and has been linked to several adverse reports of hallucinations or stroke-like ...
The U.S Food and Drug Administration and the CDC have confirmed the link between a contaminated docusate sodium solution made by PharmaTech and a multistate outbreak of Burkholderia cepacia infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results